Related Experiment Video
Updated: Aug 13, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Prostate cancer gene therapy and the role of radiation
J M Kaminski1, K Nguyen, M Buyyounouski
1Department of Radiation Oncology, Fox Chase Cancer Center, 7701 Burolme Avenue, Philadelphia, PA 19111, USA. JM_Kaminski@FCCC.edu
Abstract:
Even though prostate cancer is detected earlier than in the pre-PSA era, prostate cancer is the second leading cause of cancer mortality in the American male. Prostate cancer therapy is not ideal, especially for high-risk localized and metastatic cancer; therefore, investigators have sought new therapeutic modalities such as angiogenesis inhibitors, inhibitors of the cell signaling pathway, vaccines, and gene therapy. Gene therapy has emerged as potential therapy for both localized and systemic prostate cancer. Gene therapy has been shown to work supra-additively with radiation in controlling prostate cancer in vivo. With further technological advances in radiation therapy, gene therapy, and the understanding of prostate cancer biology, gene therapy will potentially have an important role in prostate cancer therapy.
Insights
Gene therapy offers a promising new approach for treating prostate cancer, especially when combined with radiation. Further research into gene therapy and prostate cancer biology could lead to improved treatment options.
Area of Science:
- Oncology
- Molecular Biology
- Radiotherapy
Background:
- Prostate cancer remains a leading cause of cancer mortality in American men, despite earlier detection.
- Current therapies are insufficient for high-risk localized and metastatic prostate cancer.
- New therapeutic strategies are actively being investigated.
Purpose of the Study:
- To explore gene therapy as a novel treatment modality for prostate cancer.
- To evaluate the potential of gene therapy in combination with radiation therapy.
Main Methods:
- Review of existing research on gene therapy for prostate cancer.
- Analysis of in vivo studies investigating the efficacy of gene therapy combined with radiation.
Main Results:
- Gene therapy has shown potential as a treatment for both localized and systemic prostate cancer.
- Gene therapy demonstrated supra-additive effects with radiation in controlling prostate cancer in vivo.
Conclusions:
- Gene therapy is an emerging and promising therapeutic option for prostate cancer.
- The combination of advanced radiation therapy and gene therapy holds significant potential for future prostate cancer treatment.
- Continued advancements in understanding prostate cancer biology will further enhance the role of gene therapy.
Related Concept Videos
Gene Therapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

